Effects of dietary selenium supplementation on DNA damage and apoptosis in canine prostate

Journal of the National Cancer Institute

Volumn 95, Issue 3, 2003, Pages 237-241

  Waters, David J ^a,b   Shen, Shuren ^a,b   Cooley, Dawn M ^a,b   Bostwick, David G ^c   Qian, Junqi ^c   Combs Jr , Gerald F ^d   Glickman, Lawrence T ^a   Oteham, Carol ^a   Schlittler, Deborah ^a   Morris, J Steven ^e  

^a PURDUE UNIVERSITY   (United States)

^b Gerald P Murphy Cancer Foundation   (United States)

^c Bostwick Laboratory   (United States)

^d Department of Obstetrics Gynecology   (United States)

^e UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA NUCLEOTIDYLEXOTRANSFERASE; GLUTATHIONE PEROXIDASE; SCIENCE DIET; SELENIUM; SELENOEXCELL; SELENOMETHIONINE;

AGED; AGING; ANALYSIS OF VARIANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CARCINOGENESIS; COMET ASSAY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DNA DAMAGE; DOG; MALE; NICK END LABELING; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; RANDOMIZATION; YEAST;

EID: 0037420025     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/95.3.237     Document Type: Article

References (32)

1. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin 2002;52:23-47.
2. Combs GF Jr. Considering the mechanisms of cancer prevention by selenium. Adv Exp Med Biol 2001;492:107-17.
3. Ip C, Thompson HJ, Ganther HE. Selenium modulation of cell proliferation and cell cycle biomarkers in normal and premalignant cells of the rat mammary gland. Cancer Epidemiol Biomarkers Prev 2000;9:49-54.
4. Ip C, Hayes C, Budnick RM, Ganther HE. Chemical form of selenium, critical metabolites, and cancer prevention. Cancer Res 1991;51:595-600.
5. Ames BN. Endogenous DNA damage as related to cancer and aging. Mutat Res 1989; 214:41-6.
6. Loft S, Poulsen HE. Cancer risk and oxidative DNA damage in man. J Mol Med 1996; 74:297-312.
7. Marnett LJ. Oxyradicals and DNA damage. Carcinogenesis 2000;21:361-70.
8. Ripple MO, Henry WF, Rago RP, Wilding G. Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells. J Natl Cancer Inst 1997;89: 40-8.
9. Bostwick DG, Alexander EE, Singh R, Shan A, Qian J, Santella RM, et al. Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer. Cancer 2000;89:123-34.
10. Oberley TD, Zhong W, Szweda LI, Oberley LW. Localization of antioxidant enzymes and oxidative damage products in normal and malignant prostate epithelium. Prostate 2000; 44:144-55.
11. Baker AM, Oberley LW, Cohen MB. Expression of antioxidant enzymes in human prostatic adenocarcinoma. Prostate 1997;32: 229-33.
12. Waters DJ, Sakr WA, Hayden DW, Lang CM, McKinney L, Murphy GP, et al. Work-group 4: spontaneous prostate carcinoma in dogs and nonhuman primates. Prostate 1998; 36:64-7.
13. Waters DJ, Patronek GJ, Bostwick DG, Glickman LT. Comparing the age at prostate cancer diagnosis in humans and dogs. J Natl Cancer Inst 1996;88:1686-7.
14. Clark LC, Combs GF Jr, Turnbull BW, Slate E, Alberts D, Abele D, et al. The nutritional prevention of cancer with selenium 1983-1993: a randomized clinical trial. JAMA 1996;276:1957-63.
15. Knapp DW, Leibnitz RR, DeNicola DB, Turek JJ, Teclaw R, Shaffer L, et al. Measurement of NK activity in effector cells purified from canine peripheral lymphocytes. Vet Immunol Immunopathol 1993;35: 239-51.
16. Wunderli PS, Felsburg PJ. An improved method for the isolation of enriched canine peripheral blood mononuclear cell and peripheral blood lymphocyte preparations. Vet Immunol Immunopathol 1989;20:335-44.
17. Shen S, Cooley DM, Glickman LT, Glickman N, Waters DJ. Reduction in DNA damage in brain and peripheral blood lymphocytes in elderly dogs after treatment with dehydroepiandrosterone (DHEA). Mutat Res 2001;480-481:153-62.
18. 2000 report of the AVMA Panel on Euthanasia. J Am Vet Med Assoc 2001;218: 669-96.
19. Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 1988;175:184-91.
20. Collins AR, Ma AG, Duthie SJ. The kinetics of repair of oxidative DNA damage (strand breaks and oxidised pyrimidines) in human cells. Mutat Res 1995;336:69-77.
21. Duthie SJ, Collins AR. The influence of cell growth, detoxifying enzymes and DNA repair on hydrogen peroxide-mediated DNA damage (measured using the comet assay) in human cells. Free Radic Biol Med 1997;22: 717-24.
22. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
23. Lawrence RA, Burk RF. Glutathione peroxidase activity in selenium-deficient rat liver. Biochem Biophys Res Commun 1976;71: 952-8.
24. Tice RR, Andrews PW, Hirai O, Singh NP. The single cell gel (SCG) assay: an electrophoretic technique for the detection of DNA damage in individual cells. In: Whitmer CR, Snyder RR, Jollow DJ, Kalf GF, Kocsis JJ, Sipes IG, editors. Biological reactive intermediates IV. Molecular and cellular effects and their impact on human health. New York NY): Plenum Press; 1991. p. 157-64.
25. Yoshizawa K, Willett WC, Morris SJ, Stampfer MJ, Spiegelman D, Rimm EB, et al. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst 1998;90: 1219-24.
26. Ip C. Lessons from basic research in selenium and cancer prevention. J Nutr 1998;128: 1845-54.
27. Menter DG, Sabichi AL, Lippman SM. Selenium effects on prostate cell growth. Cancer Epidemiol Biomarkers Prev 2000;9: 1171-82.
28. Seo YR, Sweeney C, Smith ML. Selenomethionine induction of DNA repair response in human fibroblasts. Oncogene 2002;21: 3663-9.
29. Lanfear J, Fleming J, Wu L, Webster G, Harrison PR. The selenium metabolite selenodiglutathione induces p53 and apoptosis: relevance to the chemopreventive effects of selenium. Carcinogenesis 1994;15:1387-92.
30. Jiang C, Wang Z, Ganther H, Lu J. Caspases as key executors of methyl selenium-induced apoptosis (anoikis) of DU-145 prostate cancer cells. Cancer Res 2001;61:3062-70.
31. 2 induces apoptosis with down-regulation of Bcl-2 and up-regulation of P53 expression in both immortal human hepatic cell line and hepatoma cell line. Mutat Res 2001; 490:113-21.
32. Jung U, Zheng X, Yoon SO, Chung AS. Semethylselenocysteine induces apoptosis mediated by reactive oxygen species in HL-60 cells. Free Radic Biol Med 2001;31:479-89.